TreeWAS – Variant ID: rs1906528

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z03.8 Observation for other suspected diseases and conditions	0.000	0.948	0.052
Y83.1 Surgical operation with implant of artificial internal device	0.000	0.973	0.027
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.977	0.023
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.978	0.022
T40.2 Other opioids	0.000	0.978	0.022
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.978	0.022
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.978	0.022
T40.4 Other synthetic narcotics	0.000	0.980	0.020
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.980	0.020
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.981	0.019
T43.2 Other and unspecified antidepressants	0.000	0.981	0.019
T42.4 Benzodiazepines	0.000	0.982	0.018
T40.5 Cocaine	0.000	0.982	0.018
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.982	0.018
T39.0 Salicylates	0.000	0.982	0.018
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.982	0.018
T40.1 Heroin	0.000	0.982	0.017
T40.3 Methadone	0.000	0.983	0.017
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.983	0.017
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.983	0.017
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.983	0.017
T40.8 Lysergide [LSD]	0.000	0.983	0.017
T40.7 Cannabis (derivatives)	0.000	0.983	0.017
T40.0 Opium	0.000	0.983	0.017
T43.6 Psychostimulants with abuse potential	0.000	0.983	0.016
J38.3 Other diseases of vocal cords	0.000	0.984	0.016
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.984	0.016
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.984	0.016
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.984	0.016
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.984	0.016
T39.1 4-Aminophenol derivatives	0.000	0.984	0.016
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.984	0.016
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.984	0.016
T43.9 Psychotropic drug, unspecified	0.000	0.984	0.015
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.984	0.015
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.984	0.015
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.984	0.015
T40.6 Other and unspecified narcotics	0.000	0.985	0.015
T42.3 Barbiturates	0.000	0.985	0.015
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.985	0.015
T47.2 Stimulant laxatives	0.000	0.985	0.015
T39.4 Antirheumatics, not elsewhere classified	0.000	0.985	0.014
T39.2 Pyrazolone derivatives	0.000	0.985	0.014
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.986	0.014
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.986	0.014
T36 Poisoning by systemic antibiotics	0.000	0.986	0.014
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.986	0.014
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.986	0.014
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.986	0.014
T42.2 Succinimides and oxazolidinediones	0.000	0.986	0.014
T38.0 Glucocorticoids and synthetic analogues	0.000	0.986	0.014
T47.4 Other laxatives	0.000	0.986	0.013
T42.0 Hydantoin derivatives	0.000	0.986	0.013
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.986	0.013
T47.6 Antidiarrhoeal drugs	0.000	0.987	0.013
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.987	0.013
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.987	0.013
T38.9 Other and unspecified hormone antagonists	0.000	0.987	0.013
T38.7 Androgens and anabolic congeners	0.000	0.987	0.013
T38.4 Oral contraceptives	0.000	0.987	0.013
T38.2 Antithyroid drugs	0.000	0.987	0.013
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.987	0.013
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.987	0.013
T38.5 Other oestrogens and progestogens	0.000	0.987	0.013
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.987	0.013
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.987	0.013
T47.7 Emetics	0.000	0.987	0.013
T47.5 Digestants	0.000	0.987	0.013
T47.3 Saline and osmotic laxatives	0.000	0.987	0.013
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.987	0.013
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.987	0.013
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.987	0.013
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.987	0.013
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.987	0.013
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.987	0.013
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.987	0.012
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.988	0.012
T37.5 Antiviral drugs	0.000	0.988	0.012
T37.4 Anthelminthics	0.000	0.988	0.012
T37.3 Other antiprotozoal drugs	0.000	0.988	0.012
T37.1 Antimycobacterial drugs	0.000	0.988	0.012
T37.0 Sulphonamides	0.000	0.988	0.012
T47.0 Histamine H(2)-receptor antagonists	0.000	0.988	0.012
T38.1 Thyroid hormones and substitutes	0.000	0.988	0.012
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.988	0.012
N87.1 Moderate cervical dysplasia	0.012	0.988	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.988	0.012
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.988	0.012
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.988	0.012
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.988	0.012
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.988	0.012
T44.0 Anticholinesterase agents	0.000	0.988	0.012
T46.1 Calcium-channel blockers	0.000	0.988	0.012
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.988	0.011
T46.7 Peripheral vasodilators	0.000	0.988	0.011
T49.9 Topical agent, unspecified	0.000	0.988	0.011
T49.8 Other topical agents	0.000	0.988	0.011
T49.7 Dental drugs, topically applied	0.000	0.988	0.011
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.988	0.011
T49.5 Ophthalmological drugs and preparations	0.000	0.988	0.011
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.988	0.011
T49.3 Emollients, demulcents and protectants	0.000	0.988	0.011
T49.2 Local astringents and local detergents	0.000	0.988	0.011
T49.1 Antipruritics	0.000	0.988	0.011
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.989	0.011
T41.5 Therapeutic gases	0.000	0.989	0.011
T41.4 Anaesthetic, unspecified	0.000	0.989	0.011
T41.3 Local anaesthetics	0.000	0.989	0.011
T41.1 Intravenous anaesthetics	0.000	0.989	0.011
T41.0 Inhaled anaesthetics	0.000	0.989	0.011
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.989	0.011
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.989	0.011
T48.4 Expectorants	0.000	0.989	0.011
T48.3 Antitussives	0.000	0.989	0.011
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.989	0.011
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.989	0.011
T48.0 Oxytocic drugs	0.000	0.989	0.011
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.989	0.011
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.989	0.011
T42.1 Iminostilbenes	0.000	0.989	0.011
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.989	0.011
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.989	0.011
T41.2 Other and unspecified general anaesthetics	0.000	0.989	0.011
T36.8 Other systemic antibiotics	0.000	0.989	0.011
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.989	0.010
T48.5 Anti-common-cold drugs	0.000	0.989	0.010
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.989	0.010
T36.4 Tetracyclines	0.000	0.989	0.010
T36.9 Systemic antibiotic, unspecified	0.000	0.989	0.010
T36.7 Antifungal antibiotics, systemically used	0.000	0.989	0.010
T36.6 Rifamycins	0.000	0.989	0.010
T36.5 Aminoglycosides	0.000	0.989	0.010
T36.2 Chloramphenicol group	0.000	0.989	0.010
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.989	0.010
T50.7 Analeptics and opioid receptor antagonists	0.000	0.990	0.010
T50.5 Appetite depressants	0.000	0.990	0.010
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.990	0.010
T50.0 Mineralocorticoids and their antagonists	0.000	0.990	0.010
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.990	0.010
T50.8 Diagnostic agents	0.000	0.990	0.010
T50.4 Drugs affecting uric acid metabolism	0.000	0.990	0.010
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.990	0.010
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.990	0.010
T45.8 Other primarily systemic and haematological agents	0.000	0.990	0.010
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.990	0.010
T45.6 Fibrinolysis-affecting drugs	0.000	0.990	0.010
T45.3 Enzymes, not elsewhere classified	0.000	0.990	0.010
T45.0 Antiallergic and antiemetic drugs	0.000	0.990	0.010
T45.5 Anticoagulants	0.000	0.990	0.010
T45.2 Vitamins, not elsewhere classified	0.000	0.990	0.010
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.990	0.010
T36.3 Macrolides	0.000	0.990	0.010
T50.1 Loop [high-ceiling] diuretics	0.000	0.990	0.010
T45.4 Iron and its compounds	0.000	0.990	0.010
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.990	0.010
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.990	0.009
G45.9 Transient cerebral ischaemic attack, unspecified	0.009	0.991	0.000
T36.0 Penicillins	0.000	0.991	0.009
T51.0 Ethanol	0.000	0.991	0.009
H53.9 Visual disturbance, unspecified	0.000	0.992	0.008
N05.9 Unspecified	0.000	0.992	0.008
R12 Heartburn	0.000	0.992	0.008
T51 Toxic effect of alcohol	0.000	0.993	0.007
T51.9 Alcohol, unspecified	0.000	0.993	0.007
G45 Transient cerebral ischaemic attacks and related syndromes	0.007	0.993	0.000
C67.9 Bladder, unspecified	0.000	0.993	0.007
H53.2 Diplopia	0.000	0.993	0.007
N03.9 Unspecified	0.000	0.993	0.007
N05 Unspecified nephritic syndrome	0.000	0.993	0.007
H53 Visual disturbances	0.000	0.993	0.007
G45.8 Other transient cerebral ischaemic attacks and related syndromes	0.006	0.994	0.000
G45.1 Carotid artery syndrome (hemispheric)	0.006	0.994	0.000
G45.3 Amaurosis fugax	0.006	0.994	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.000	0.994	0.006
G45.0 Vertebro-basilar artery syndrome	0.006	0.994	0.000
C54.1 Endometrium	0.000	0.994	0.006
H53.1 Subjective visual disturbances	0.000	0.994	0.006
N03 Chronic nephritic syndrome	0.000	0.994	0.006
T51.8 Other alcohols	0.000	0.994	0.005
T51.3 Fusel oil	0.000	0.994	0.005
T51.2 2-Propanol	0.000	0.994	0.005
T51.1 Methanol	0.000	0.994	0.005
G45.2 Multiple and bilateral precerebral artery syndromes	0.005	0.995	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.995	0.005
G45.4 Transient global amnesia	0.005	0.995	0.000
H53.5 Colour vision deficiencies	0.000	0.995	0.005
N00-N08 Glomerular diseases	0.000	0.995	0.005
I84.1 Internal haemorrhoids with other complications	0.000	0.995	0.005
N05.2 Diffuse membranous glomerulonephritis	0.000	0.995	0.005
H53.3 Other disorders of binocular vision	0.000	0.995	0.005
N05.6 Dense deposit disease	0.000	0.995	0.005
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.995	0.005
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.995	0.005
N05.0 Minor glomerular abnormality	0.000	0.995	0.005
H53.6 Night blindness	0.000	0.995	0.005
N04 Nephrotic syndrome	0.000	0.995	0.005
N05.1 Focal and segmental glomerular lesions	0.000	0.995	0.005
N05.8 Other	0.000	0.995	0.005
N04.9 Unspecified	0.000	0.995	0.005
H53.8 Other visual disturbances	0.000	0.995	0.005
N03.8 Other	0.000	0.996	0.004
H53.4 Visual field defects	0.000	0.996	0.004
N03.7 Diffuse crescentic glomerulonephritis	0.000	0.996	0.004
N03.6 Dense deposit disease	0.000	0.996	0.004
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.996	0.004
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.996	0.004
N03.0 Minor glomerular abnormality	0.000	0.996	0.004
N03.2 Diffuse membranous glomerulonephritis	0.000	0.996	0.004
O03.4 Incomplete, without complication	0.004	0.996	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.000	0.996	0.004
O36.5 Maternal care for poor foetal growth	0.004	0.996	0.000
H53.0 Amblyopia ex anopsia	0.000	0.996	0.004
N03.1 Focal and segmental glomerular lesions	0.000	0.996	0.004
N04.8 Other	0.000	0.996	0.004
N07 Hereditary nephropathy, not elsewhere classified	0.000	0.996	0.004
N06 Isolated proteinuria with specified morphological lesion	0.000	0.996	0.004
N01 Rapidly progressive nephritic syndrome	0.000	0.996	0.004
O36 Maternal care for other known or suspected foetal problems	0.004	0.996	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.996	0.004
O03.9 Complete or unspecified, without complication	0.004	0.996	0.000
N00 Acute nephritic syndrome	0.000	0.996	0.004
F10.2 Dependence syndrome	0.000	0.996	0.004
O36.9 Maternal care for foetal problem, unspecified	0.004	0.996	0.000
O03 Spontaneous abortion	0.004	0.996	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.000	0.996	0.004
N04.6 Dense deposit disease	0.000	0.996	0.004
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.996	0.004
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.996	0.004
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.996	0.004
J84.1 Other interstitial pulmonary diseases with fibrosis	0.004	0.996	0.000
N04.2 Diffuse membranous glomerulonephritis	0.000	0.996	0.004
N04.1 Focal and segmental glomerular lesions	0.000	0.996	0.004
N04.0 Minor glomerular abnormality	0.000	0.996	0.004
O36.0 Maternal care for rhesus isoimmunisation	0.004	0.996	0.000
Y86 Sequelae of other accidents	0.004	0.996	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.000	0.996	0.004
O36.8 Maternal care for other specified foetal problems	0.004	0.996	0.000
O36.4 Maternal care for intra-uterine death	0.003	0.997	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.000	0.997	0.003
N08.3 Glomerular disorders in diabetes mellitus	0.000	0.997	0.003
C18.2 Ascending colon	0.000	0.997	0.003
O03.3 Incomplete, with other and unspecified complications	0.003	0.997	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.000	0.997	0.003
N08.8 Glomerular disorders in other diseases classified elsewhere	0.000	0.997	0.003
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
T59 Toxic effect of other gases, fumes and vapours	0.000	0.997	0.003
N08.1 Glomerular disorders in neoplastic diseases	0.000	0.997	0.003
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.000	0.997	0.003
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.003	0.997	0.000
O36.6 Maternal care for excessive foetal growth	0.003	0.997	0.000
O36.3 Maternal care for signs of foetal hypoxia	0.003	0.997	0.000
N01.9 Unspecified	0.000	0.997	0.003
N01.8 Other	0.000	0.997	0.003
N01.7 Diffuse crescentic glomerulonephritis	0.000	0.997	0.003
N01.6 Dense deposit disease	0.000	0.997	0.003
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.997	0.003
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.997	0.003
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.997	0.003
N01.2 Diffuse membranous glomerulonephritis	0.000	0.997	0.003
N01.1 Focal and segmental glomerular lesions	0.000	0.997	0.003
N01.0 Minor glomerular abnormality	0.000	0.997	0.003
N06.9 Unspecified	0.000	0.997	0.003
N06.8 Other	0.000	0.997	0.003
N06.7 Diffuse crescentic glomerulonephritis	0.000	0.997	0.003
N06.6 Dense deposit disease	0.000	0.997	0.003
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.997	0.003
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.997	0.003
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.997	0.003
N06.2 Diffuse membranous glomerulonephritis	0.000	0.997	0.003
N06.1 Focal and segmental glomerular lesions	0.000	0.997	0.003
N06.0 Minor glomerular abnormality	0.000	0.997	0.003
N07.9 Unspecified	0.000	0.997	0.003
N07.8 Other	0.000	0.997	0.003
N07.7 Diffuse crescentic glomerulonephritis	0.000	0.997	0.003
N07.6 Dense deposit disease	0.000	0.997	0.003
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.997	0.003
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.997	0.003
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.997	0.003
N07.2 Diffuse membranous glomerulonephritis	0.000	0.997	0.003
N07.1 Focal and segmental glomerular lesions	0.000	0.997	0.003
N07.0 Minor glomerular abnormality	0.000	0.997	0.003
O03.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.003	0.997	0.000
O36.2 Maternal care for hydrops foetalis	0.003	0.997	0.000
O03.8 Complete or unspecified, with other and unspecified complications	0.003	0.997	0.000
T62 Toxic effect of other noxious substances eaten as food	0.000	0.997	0.003
N00.8 Other	0.000	0.997	0.003
N00.7 Diffuse crescentic glomerulonephritis	0.000	0.997	0.003
N00.6 Dense deposit disease	0.000	0.997	0.003
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.997	0.003
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.997	0.003
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.997	0.003
N00.2 Diffuse membranous glomerulonephritis	0.000	0.997	0.003
N00.1 Focal and segmental glomerular lesions	0.000	0.997	0.003
N00.0 Minor glomerular abnormality	0.000	0.997	0.003
N08.5 Glomerular disorders in systemic connective tissue disorders	0.000	0.997	0.003
O03.7 Complete or unspecified, complicated by embolism	0.003	0.997	0.000
O03.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.003	0.997	0.000
O03.2 Incomplete, complicated by embolism	0.003	0.997	0.000
O03.0 Incomplete, complicated by genital tract and pelvic infection	0.003	0.997	0.000
T59.8 Other specified gases, fumes and vapours	0.000	0.997	0.003
T52 Toxic effect of organic solvents	0.000	0.997	0.003
T54 Toxic effect of corrosive substances	0.000	0.997	0.003
N00.9 Unspecified	0.000	0.997	0.003
F10.1 Harmful use	0.000	0.997	0.003
Z46.2 Fitting and adjustment of other devices related to nervous system and special senses	0.000	0.997	0.003
O36.1 Maternal care for other isoimmunisation	0.003	0.997	0.000
O03.1 Incomplete, complicated by delayed or excessive haemorrhage	0.003	0.997	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.003	0.997	0.000
C67 Malignant neoplasm of bladder	0.000	0.997	0.003
Z91.5 Personal history of self-harm	0.000	0.997	0.003
T61 Toxic effect of noxious substances eaten as seafood	0.000	0.997	0.003
T60 Toxic effect of pesticides	0.000	0.997	0.003
T57 Toxic effect of other inorganic substances	0.000	0.997	0.003
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.000	0.997	0.003
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.000	0.997	0.003
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.000	0.997	0.003
T65 Toxic effect of other and unspecified substances	0.000	0.997	0.003
T55 Toxic effect of soaps and detergents	0.000	0.997	0.003
S22.30 Fracture of rib (closed)	0.003	0.997	0.000
C18.0 Caecum	0.000	0.997	0.003
G47.9 Sleep disorder, unspecified	0.003	0.997	0.000
T62.9 Noxious substance eaten as food, unspecified	0.000	0.997	0.003
J84.9 Interstitial pulmonary disease, unspecified	0.003	0.997	0.000
C18.1 Appendix	0.000	0.997	0.003
T56 Toxic effect of metals	0.000	0.997	0.002
T59.9 Gases, fumes and vapours, unspecified	0.000	0.997	0.002
C54 Malignant neoplasm of corpus uteri	0.000	0.997	0.003
C67.4 Posterior wall of bladder	0.000	0.997	0.003
T59.7 Carbon dioxide	0.000	0.997	0.002
T59.6 Hydrogen sulphide	0.000	0.997	0.002
T59.5 Fluorine gas and hydrogen fluoride	0.000	0.997	0.002
T59.4 Chlorine gas	0.000	0.997	0.002
T59.3 Lachrymogenic gas	0.000	0.997	0.002
T59.2 Formaldehyde	0.000	0.997	0.002
T59.1 Sulphur dioxide	0.000	0.997	0.002
T59.0 Nitrogen oxides	0.000	0.997	0.002
T52.8 Other organic solvents	0.000	0.997	0.002
T58 Toxic effect of carbon monoxide	0.000	0.997	0.002
T54.9 Corrosive substance, unspecified	0.000	0.997	0.002
J84 Other interstitial pulmonary diseases	0.002	0.997	0.000
T62.8 Other specified noxious substances eaten as food	0.000	0.997	0.002
T62.2 Other ingested (parts of) plant(s)	0.000	0.997	0.002
T62.1 Ingested berries	0.000	0.997	0.002
T62.0 Ingested mushrooms	0.000	0.997	0.002
C67.2 Lateral wall of bladder	0.000	0.998	0.002
I84.6 Residual haemorrhoidal skin tags	0.000	0.998	0.002
T52.9 Organic solvent, unspecified	0.000	0.998	0.002
T52.4 Ketones	0.000	0.998	0.002
T52.3 Glycols	0.000	0.998	0.002
T52.2 Homologues of benzene	0.000	0.998	0.002
T52.1 Benzene	0.000	0.998	0.002
T52.0 Petroleum products	0.000	0.998	0.002
T63 Toxic effect of contact with venomous animals	0.000	0.998	0.002
C67.8 Overlapping lesion of bladder	0.000	0.998	0.002
R56.8 Other and unspecified convulsions	0.000	0.998	0.002
T54.3 Corrosive alkalis and alklali-like substances	0.000	0.998	0.002
T54.2 Corrosive acids and acid-like substances	0.000	0.998	0.002
T54.1 Other corrosive organic compounds	0.000	0.998	0.002
T54.0 Phenol and phenol homologues	0.000	0.998	0.002
F10 Mental and behavioural disorders due to use of alcohol	0.000	0.998	0.002
C67.7 Urachus	0.000	0.998	0.002
N02 Recurrent and persistent haematuria	0.000	0.998	0.002
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified	0.000	0.998	0.002
T53.7 Other halogen derivatives of aromatic hydrocarbons	0.000	0.998	0.002
T53.6 Other halogen derivatives of aliphatic hydrocarbons	0.000	0.998	0.002
T53.5 Chlorofluorocarbons	0.000	0.998	0.002
T53.4 Dichloromethane	0.000	0.998	0.002
T53.3 Tetrachloroethylene	0.000	0.998	0.002
T53.2 Trichloroethylene	0.000	0.998	0.002
T53.1 Chloroform	0.000	0.998	0.002
T53.0 Carbon tetrachloride	0.000	0.998	0.002
T57.9 Inorganic substance, unspecified	0.000	0.998	0.002
T57.8 Other specified inorganic substances	0.000	0.998	0.002
T57.3 Hydrogen cyanide	0.000	0.998	0.002
T57.2 Manganese and its compounds	0.000	0.998	0.002
T57.1 Phosphorus and its compounds	0.000	0.998	0.002
T57.0 Arsenic and its compounds	0.000	0.998	0.002
T60.9 Pesticide, unspecified	0.000	0.998	0.002
T60.8 Other pesticides	0.000	0.998	0.002
T60.4 Rodenticides	0.000	0.998	0.002
T60.3 Herbicides and fungicides	0.000	0.998	0.002
T60.2 Other insecticides	0.000	0.998	0.002
T60.1 Halogenated insecticides	0.000	0.998	0.002
T60.0 Organophosphate and carbamate insecticides	0.000	0.998	0.002
T61.9 Toxic effect of unspecified seafood	0.000	0.998	0.002
T61.8 Toxic effect of other seafoods	0.000	0.998	0.002
T61.2 Other fish and shellfish poisoning	0.000	0.998	0.002
T61.1 Scombroid fish poisoning	0.000	0.998	0.002
T61.0 Ciguatera fish poisoning	0.000	0.998	0.002
C67.3 Anterior wall of bladder	0.000	0.998	0.002
T65.8 Toxic effect of other specified substances	0.000	0.998	0.002
T65.6 Paints and dyes, not elsewhere classified	0.000	0.998	0.002
T65.5 Nitroglycerin and other nitric acids and esters	0.000	0.998	0.002
T65.4 Carbon disulphide	0.000	0.998	0.002
T65.3 Nitroderivatives and aminoderivatives of benzene and its homologues	0.000	0.998	0.002
T65.2 Tobacco and nicotine	0.000	0.998	0.002
T65.1 Strychnine and its salts	0.000	0.998	0.002
T65.0 Cyanides	0.000	0.998	0.002
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.000	0.998	0.002
Z91 Personal history of risk-factors, not elsewhere classified	0.000	0.998	0.002
T65.9 Toxic effect of unspecified substance	0.000	0.998	0.002
C67.1 Dome of bladder	0.000	0.998	0.002
G41.9 Status epilepticus, unspecified	0.002	0.998	0.000
G40-G47 Episodic and paroxysmal disorders	0.002	0.998	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.002	0.998	0.000
T56.9 Metal, unspecified	0.000	0.998	0.002
T56.7 Beryllium and its compounds	0.000	0.998	0.002
T56.6 Tin and its compounds	0.000	0.998	0.002
T56.5 Zinc and its compounds	0.000	0.998	0.002
T56.4 Copper and its compounds	0.000	0.998	0.002
T56.3 Cadmium and its compounds	0.000	0.998	0.002
T56.2 Chromium and its compounds	0.000	0.998	0.002
T56.1 Mercury and its compounds	0.000	0.998	0.002
T56.0 Lead and its compounds	0.000	0.998	0.002
C18 Malignant neoplasm of colon	0.000	0.998	0.002
G41 Status epilepticus	0.002	0.998	0.000
C54.8 Overlapping lesion of corpus uteri	0.000	0.998	0.002
C54.3 Fundus uteri	0.000	0.998	0.002
C54.2 Myometrium	0.000	0.998	0.002
C54.0 Isthmus uteri	0.000	0.998	0.002
Z91.0 Personal history of allergy, other than to drugs and biological substances	0.000	0.998	0.002
C18.5 Splenic flexure	0.000	0.998	0.002
G44.2 Tension-type headache	0.002	0.998	0.000
G44 Other headache syndromes	0.002	0.998	0.000
H53-H54 Visual disturbances and blindness	0.000	0.998	0.002
C54.9 Corpus uteri, unspecified	0.000	0.998	0.002
C67.0 Trigone of bladder	0.000	0.998	0.002
M35.3 Polymyalgia rheumatica	0.002	0.998	0.000
Z91.4 Personal history of psychological trauma, not elsewhere classified	0.000	0.998	0.002
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.998	0.002
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities	0.000	0.998	0.002
G47 Sleep disorders	0.002	0.998	0.000
C67.5 Bladder neck	0.000	0.998	0.002
I42.0 Dilated cardiomyopathy	0.000	0.998	0.002
S64.0 Injury of ulnar nerve at wrist and hand level	0.002	0.998	0.000
N02.0 Minor glomerular abnormality	0.000	0.998	0.002
J84.0 Alveolar and parietoalveolar conditions	0.002	0.998	0.000
T56.8 Other metals	0.000	0.998	0.002
T63.8 Toxic effect of contact with other venomous animals	0.000	0.998	0.002
T63.6 Toxic effect of contact with other marine animals	0.000	0.998	0.002
T63.5 Toxic effect of contact with fish	0.000	0.998	0.002
T63.3 Venom of spider	0.000	0.998	0.002
T63.2 Venom of scorpion	0.000	0.998	0.002
T63.1 Venom of other reptiles	0.000	0.998	0.002
T63.0 Snake venom	0.000	0.998	0.002
J38.5 Laryngeal spasm	0.000	0.998	0.002
N02.1 Focal and segmental glomerular lesions	0.000	0.998	0.002
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.002	0.998	0.000
T63.9 Toxic effect of contact with unspecified venomous animal	0.000	0.998	0.002
F10.8 Other mental and behavioural disorders	0.000	0.998	0.002
F10.0 Acute intoxication	0.000	0.998	0.002
N02.7 Diffuse crescentic glomerulonephritis	0.000	0.998	0.002
N02.6 Dense deposit disease	0.000	0.998	0.002
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.998	0.002
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.000	0.998	0.002
C67.6 Ureteric orifice	0.000	0.998	0.002
G41.8 Other status epilepticus	0.002	0.998	0.000
F10.9 Unspecified mental and behavioural disorder	0.000	0.998	0.002
G44.8 Other specified headache syndromes	0.002	0.998	0.000
J38.7 Other diseases of larynx	0.000	0.998	0.002
Z91.7 Personal history of female genital mutilation	0.000	0.998	0.002
Z91.3 Personal history of unhealthy sleep-wake schedule	0.000	0.998	0.002
F10.3 Withdrawal state	0.000	0.998	0.002
G47.8 Other sleep disorders	0.002	0.998	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.000	0.998	0.002
N02.2 Diffuse membranous glomerulonephritis	0.000	0.998	0.002
O00-O08 Pregnancy with abortive outcome	0.002	0.998	0.000
G41.2 Complex partial status epilepticus	0.002	0.998	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.998	0.002
J38.6 Stenosis of larynx	0.000	0.998	0.002
M35.0 Sicca syndrome [Sjogren]	0.002	0.998	0.000
F10.7 Residual and late-onset psychotic disorder	0.000	0.998	0.002
G44.4 Drug-induced headache, not elsewhere classified	0.002	0.998	0.000
S64.1 Injury of median nerve at wrist and hand level	0.002	0.998	0.000
G41.1 Petit mal status epilepticus	0.002	0.998	0.000
G47.4 Narcolepsy and cataplexy	0.002	0.998	0.000
M54.39 Sciatica (Site unspecified)	0.000	0.998	0.002
F10.5 Psychotic disorder	0.000	0.998	0.002
Y40.0 Penicillins	0.002	0.998	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
C18.6 Descending colon	0.000	0.998	0.002
J84.8 Other specified interstitial pulmonary diseases	0.002	0.998	0.000
C18.3 Hepatic flexure	0.000	0.998	0.002
F10.6 Amnesic syndrome	0.000	0.998	0.002
G44.3 Chronic posttraumatic headache	0.002	0.998	0.000
K63.9 Disease of intestine, unspecified	0.000	0.998	0.002
S64.2 Injury of radial nerve at wrist and hand level	0.002	0.998	0.000
Z87.8 Personal history of other specified conditions	0.002	0.998	0.000
Z91.8 Personal history of other specified risk-factors, not elsewhere classified	0.000	0.998	0.002
O04 Medical abortion	0.002	0.998	0.000
G82.2 Paraplegia, unspecified	0.002	0.998	0.000
C18.8 Overlapping lesion of colon	0.000	0.998	0.002
O04.9 Complete or unspecified, without complication	0.002	0.998	0.000
S64 Injury of nerves at wrist and hand level	0.002	0.998	0.000
G41.0 Grand mal status epilepticus	0.002	0.998	0.000
G44.1 Vascular headache, not elsewhere classified	0.002	0.998	0.000
G44.0 Cluster headache syndrome	0.002	0.998	0.000
J38.2 Nodules of vocal cords	0.000	0.998	0.002
O08 Complications following abortion and ectopic and molar pregnancy	0.002	0.998	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations